2021 Barrow Pituitary Symposium
Who Should Attend
Physicians, nurse practitioners, physician’s assistants, nurses and other healthcare professionals with an interest in the application of best practices involving pituitary physiology, pituitary tumors, and other neuro-endocrine disorders.
Objectives
At the end of this activity, the learner should be able to recommend the appropriate diagnostic modalities for patients with pituitary disorders with subtle clinical findings to ensure early diagnosis and intervention by pituitary specialists, describe the appropriate treatment algorithms for patients with various types of pituitary tumors, select the appropriate medical/hormonal treatment options for pituitary disorders before and after surgery as well as in lieu of surgical intervention, and recognize the importance of accurate performance of critical diagnostic testing for post-operative hormonal and electrolyte dysfunction.
Registration Information
| Attendee Type | Early Bird | Late registration |
|---|---|---|
| Physician | $150 | $200 |
| Resident / Fellow | $90 | $140 |
| NP / PA / RN | $90 | $140 |
| Dignity Health Residents / Fellows | Waived | Waived |
| Dignity Health RN / NP | Waived | Waived |
Refund and cancellation policy: Barrow reserves the right to cancel or change the program for due causes. Cancellation of this program by Barrow or by the participant before October 10th will result in a full refund of tuition.
Continuing Medical Education Credit Information
Accreditation
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American College of Surgeons and Dignity Health. The American College of Surgeons is accredited by the ACCME to provide continuing medical education for physicians.
AMA PRA Category 1 Credits™
The American College of Surgeons designates this live activity for a maximum of 6.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Date, Time, and Location
To Be Determined
Also available online
Goldman Auditorium
Barrow Neurological Institute
2910 North 3rd Avenue
Phoenix, Arizona 85013
Scroll down for campus map
Speaker Information
| SPeaker | Topic |
|---|---|
| To be Determined | To be Determined |
Disclosure Information
In accordance with the ACCME Accreditation Criteria, the American College of Surgeons must ensure that anyone in a position to control the content of the educational activity (planners and speakers/authors/discussants/moderators) has disclosed all financial relationships with any ineligible company held in the last 24 months. Please note that first authors were required to collect and submit disclosure information on behalf all other authors/contributors, if applicable.
Ineligible Company: The ACCME defines an “ineligible company” as any entity producing, marketing, re-selling, or distributing health care goods or services used on or consumed by patients. Providers of clinical services directly to patients are NOT included in this definition.
Financial Relationships: Relationships in which the individual benefits by receiving a salary, royalty, intellectual property rights, consulting fee, honoraria, ownership interest (e.g., stocks, stock options or other ownership interest, excluding diversified mutual funds), or other financial benefit. Financial benefits are usually associated with roles such as employment, management position, independent contractor (including contracted research), consulting, speaking and teaching, membership on advisory committees or review panels, board membership, and other activities from which remuneration is received, or expected. ACCME considers relationships of the person involved in the CME activity to include financial relationships of a spouse or partner.
Conflict of Interest: Circumstances create a conflict of interest when an individual has an opportunity to affect CME content about products or services of a ineligible company with which he/she has a financial relationship.
The ACCME also requires that ACS manage any reported conflict and eliminate the potential for bias during the educational activity. Any conflicts noted below have been managed to our satisfaction. The disclosure information is intended to identify any commercial relationships and allow learners to form their own judgments. However, if you perceive a bias during the educational activity, please report it on the evaluation.
| Disclosures |
|---|
| Planning Committee/Moderators/Speakers |
| Kevin Yuen, MD Financial disclosures – Research funding: Corcept, Chiasma, Ascendis, Novartis Advisory Board/Honorarium: NovoNordisk, Corcept, Recordati, Strongbridge, Chiasma, Ascendis,Ipsen, Rani Therapeutics, Sandoz |
| Andrew Little, MD Financial disclosures –Consultant/Stakeholder: Spiway, Kogent Consultant: BK Medical |
| Eva Marie Duran, MSN, FNP-C Financial disclosures – Honorarium: NovoNordisk |
| Speakers |
| Michael Garcia, MD Financial disclosures – None |
| Griffin Santarelli, MD Financial disclosures – None |
| Brian Wilhelmi, MD Financial disclosures – None |
| Roberto Salvatori, MD Financial disclosures – Consultant: Recordati, Ipsen, Strongbridge, HRA Pharma |
| Scott Brigeman, MD Financial disclosures – None |
| Douglas Hardesty, MD Financial disclosures – None |